Microplate Dx Limited
United Kingdom
- Glasgow, Lanarkshire
- 12/09/2023
- Seed
- $3,117,000
Microplate Dx Limited specialises in rapid antibiotic susceptibility testing diagnostics, enabling clinicians, at the point-of-care, to confidently select the best choice of antibiotic to treat a patient’s infection in a matter of minutes, significantly quicker than the current gold standard technology which takes at least 2 days. Our award-wining, platform diagnostic test helps reduce the major global health threat of antimicrobial resistance and ultimately, saves lives.
- Industry Medical Equipment Manufacturing
- Website https://microplatedx.com/
- LinkedIn https://www.linkedin.com/company/microplate-dx-limited/about/
Related People
Stuart HannahFounder
United Kingdom -
Greater Glasgow Area
CEO - Microplate Dx Limited.
Developing a rapid, cost-effective, direct-from-sample, antibiotic susceptibility test, which quickly identifies the best choice of antibiotic for a particular infection in minutes, significantly quicker than the current gold standard of days.
Findd.AI | $21,000,000 | (May 22, 2026)
CVRD Health | $5,000,000 | (May 22, 2026)
checker | $8,000,000 | (May 22, 2026)
Oorja Bio | $30,000,000 | (May 22, 2026)
Neurosoft Bioelectronics | $7,500,000 | (May 22, 2026)
Imperagen | $5,000,000 | (May 22, 2026)
Hark(1) | $700,000,000 | (May 22, 2026)
Dandelion Health | $14,000,000 | (May 22, 2026)
Century Health | $5,000,000 | (May 22, 2026)
shatterdome energy | $3,500,000 | (May 22, 2026)
LawX | $8,709,375 | (May 22, 2026)
Overwatch AI | $1,500,000 | (May 22, 2026)
Tribal(1) | $10,000,000 | (May 22, 2026)